AVE Science & Technology Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005188
CNY
25.15
-0.02 (-0.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
AVE Science & Technology Co., Ltd.
Why is AVE Science & Technology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 2.16%
  • The company has been able to generate a Return on Capital Employed (avg) of 2.16% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
  • Poor long term growth as Net Sales has grown by an annual rate of 1.36% and Operating profit at -5.73% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 4.79% signifying low profitability per unit of shareholders funds
3
Positive results in Mar 25
  • OPERATING CASH FLOW(Y) Highest at CNY 35.64 MM
  • NET PROFIT(HY) At CNY 3.98 MM has Grown at 59.47%
  • RAW MATERIAL COST(Y) Fallen by -2.61% (YoY)
4
With ROE of 5.02%, it has a expensive valuation with a 0.69 Price to Book Value
  • Over the past year, while the stock has generated a return of 29.99%, its profits have risen by 6.1% ; the PEG ratio of the company is 2.2
5
Market Beating Performance
  • The stock has generated a return of 29.99% in the last 1 year, much higher than market (China Shanghai Composite) returns of 14.77%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to AVE Science & Technology Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is AVE Science & Technology Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
AVE Science & Technology Co., Ltd.
33.78%
2.25
34.91%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.36%
EBIT Growth (5y)
-5.73%
EBIT to Interest (avg)
7.47
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.40
Tax Ratio
2.56%
Dividend Payout Ratio
29.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.16%
ROE (avg)
4.79%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
0.69
EV to EBIT
2.47
EV to EBITDA
1.20
EV to Capital Employed
0.15
EV to Sales
0.13
PEG Ratio
2.24
Dividend Yield
NA
ROCE (Latest)
6.21%
ROE (Latest)
5.02%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 35.64 MM

NET PROFIT(HY)

At CNY 3.98 MM has Grown at 59.47%

RAW MATERIAL COST(Y)

Fallen by -2.61% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -14.79 %

DEBTORS TURNOVER RATIO(HY)

Highest at 26.74%

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Here's what is working for AVE Science & Technology Co., Ltd.
Net Profit
At CNY 3.98 MM has Grown at 59.47%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Operating Cash Flow
Highest at CNY 35.64 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Debt-Equity Ratio
Lowest at -14.79 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 26.74%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -2.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales